Clinical problems with transdermal fentanyl titration from 25 to 50 μg/hr [2]

Journal of Pain and Symptom Management

Volumn 21, Issue 6, 2001, Pages 448-449

  Mercadante, Sebastiano ^a   Villari, Patrizia ^a   Ferrera, Patrizia ^a  

^a LA MADDALENA CANCER CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; IBUPROFEN; PROMETHAZINE; TRAMADOL;

AGED; AGGRESSION; AGITATION; ANALGESIA; BACKACHE; BONE PAIN; CANCER PAIN; CASE REPORT; CONFUSION; FEMALE; HUMAN; INSOMNIA; LETTER; MALE;

ADMINISTRATION, CUTANEOUS; ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FENTANYL; HUMANS; MALE;

EID: 0035010044     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0885-3924(01)00289-5     Document Type: Letter

References (5)

1. Quality of life and cancer pain; satisfaction and side effects with transdermal fentanyl versus oral morphine
2. Morphine in cancer pain; modes of administration
3. Pain intensity and side effects during titration of morphine to cancer patients using a fixed schedule dose escalation
4. The use of anti-inflammatory drugs in cancer pain
5. Transdermal fentanyl in opioid-naïve cancer pain patients; an open trial using transdermal fentanyl for the treatment of chronic cancer pain in opioid-naïve patients and a group using codeine